Hot Features
Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Waters to Make DAISO Media Available to Pharmaceutical and Biopharmaceutical Purification Customers MILFORD, Mass. and OSAKA, Japan, Feb. 17 /PRNewswire/ -- Waters Corporation and DAISO CO., LTD...
Vision Publisher Optimizes Workflow and Reduces Compliance Risk with Efficient Data Management MILFORD, Mass., Dec. 15 /PRNewswire-FirstCall/ -- Waters Corporation (NYSE:WAT) today announced that...
Fusion Method Development software Produces More Robust Methods Faster; Method Development Time Reduced from 45-60 Days to 2-3 Days MILFORD, Mass., Dec. 14 /PRNewswire-FirstCall/ -- Waters...
MILFORD, Mass., Dec. 9 /PRNewswire-FirstCall/ -- Waters Corporation (NYSE: WAT) announced today that it has shipped the first units of its ground-breaking SYNAPT(TM) G2 Mass Spectrometer, first...
UPLC Systems Help Support Agency's Science-Based Efforts to Protect Consumers and Ensure Food is Safe for Consumption MILFORD, Mass., Oct. 20 /PRNewswire-FirstCall/ -- Waters Corporation...
GAO Releases New Report on Food Import Challenges WASHINGTON, Oct. 14 /PRNewswire-FirstCall/ -- Waters Corporation (NYSE: WAT) today convened the 2nd Annual Global Food Safety Policy Forum with...
Waters MS Systems Handle the Most Complex Applications While Adding Simplicity Throughout the Analytical Workflow MILFORD, Mass., Aug. 27 /PRNewswire-FirstCall/ -- Waters Corporation (NYSE:WAT...
Dedicated UPLC/MS System Solutions Taking on Increased Challenges in Laboratories for Therapeutic Drug Monitoring, Disease Management, Endocrinology, and Toxicology CHICAGO, July 20...
PHILADELPHIA, June 3 /PRNewswire-FirstCall/ -- Waters Corporation (NYSE: WAT) announced today that the American Society for Mass Spectrometry (ASMS) presented Prof. Alison Ashcroft of the...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
| 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
| 12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
| 26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
| 52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
| 156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
| 260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
